4B-MAR Stats & Data

Evidence update and identity: Chiral/analytical work shows 4′‑bromo‑4‑methylaminorex (4B‑MAR) is sold online and characterized as a racemic mixture of the trans diastereomer; batches were acquired in January 2022 and resolved by chiral HPLC with LC‑HRMS/NMR confirmation. Batch‑to‑batch purity and isomeric composition can vary, so potency is uncertain—titrate cautiously.

Dose and duration context: 4‑methylaminorex (parent) is a long‑lasting stimulant (often 10–16 h active effects) and users report similar, sometimes slightly less euphoric, profiles for 4B‑MAR at sub‑25 mg to ~55 mg oral with prolonged wakefulness and modest mood lift. Treat redosing within 24 h as high‑risk due to accumulation and insomnia.

Cardiopulmonary caution: The aminorex class is historically linked to epidemics of pulmonary arterial hypertension (PAH) in the late 1960s in Switzerland, Austria, and Germany. Though 4B‑MAR itself lacks clinical data, prudence dictates avoiding chronic/frequent use, monitoring for exertional dyspnea/chest pain, and strictly avoiding combinations that markedly elevate 5‑HT or blood pressure.

Serotonergic toxicity signal from analogues: 4,4′‑DMAR is a potent triple monoamine releaser with pronounced serotonergic activity and has been involved in clusters of hyperthermic/toxic events and deaths; while 4B‑MAR is not 4,4′‑DMAR, mixing halogenated aminorexes or stacking with MDMA‑like drugs elevates risk of hyperthermia/serotonin syndrome. Keep ambient temperature reasonable, rest, and hydrate with electrolytes.

MAOI contraindication and combo hygiene: MAOIs with amphetamine‑like stimulants are widely contraindicated; combination charts and stimulant HR pages consistently flag dangerous interactions and the need to avoid “downer‑stacking” to force sleep while still stimulated. If severely wired, do not chase with alcohol/benzos; instead, allow time, cooling, and light nutrition.

Testing and verification: Because vendor quality varies and reagents may be non‑specific, consider professional LC‑MS drug‑checking where available; online halogenated 4‑MAR derivatives were specifically noted as purchased from internet vendors and not reputable chemical suppliers.

Practical dosing hygiene: Use a 0.001 g scale; for insufflation or vaping, consider volumetric solutions or sub‑mg test puffs due to steep onset. Avoid daily use; leave at least 2+ weeks between sessions to allow cardiovascular recovery and tolerance reset (conservative HR practice based on stimulant class and aminorex history).